Literature DB >> 2035662

Progressive ventricular remodeling in rat with myocardial infarction.

J M Pfeffer1, M A Pfeffer, P J Fletcher, E Braunwald.   

Abstract

Ventricular dilatation may have important prognostic implications for the survival of patients with left ventricular (LV) dysfunction. To determine the manner and extent to which the left ventricle of the rat remodels and dilates after myocardial infarction, we obtained the passive pressure-volume relationships, chamber stiffness constants, and mass during both the early and late phases. In moderate and large infarcts as inflammation and edema developed, LV weight increased then progressively decreased as a thin scar formed, returning to normal values as a result of compensatory hypertrophy of the residual myocardium. LV dilatation occurred in all rats with infarcts but to different extents depending on infarct size and duration. In the early postinfarction phase, pressure-volume relationship was relatively unchanged in all infarct-size groups, except for significant rightward shift in low pressure range for rats with moderate and large infarcts and significant leftward shift in high pressure range for rats with small infarcts. During resolution of the inflammatory response, LV dilatation occurred in all infarct groups in relation to infarct size. As scar formation became complete, LV enlargement did not progress in rats with small infarcts but did so in rats with moderate and large infarcts. LV chamber stiffness remained within the range of normal values during the early phase in all rats with infarcts but decreased significantly during the late phase in rats with moderate and large infarcts in association with the extent of ventricular enlargement. Alterations in the volume-to-mass ratio (V/Vwt) were most marked in the late postinfarction phase, wherein both volume (increased) and mass (decreased, then increased) changed dramatically and V/Vwt progressively increased in rats with large infarcts.

Entities:  

Mesh:

Year:  1991        PMID: 2035662     DOI: 10.1152/ajpheart.1991.260.5.H1406

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  114 in total

1.  Bone marrow-derived stem cells for ischemic hearts.

Authors:  Alfred A Kocher
Journal:  Wien Klin Wochenschr       Date:  2003-02-28       Impact factor: 1.704

Review 2.  The dynamic interaction between matrix metalloproteinase activity and adverse myocardial remodeling.

Authors:  Joseph S Janicki; Gregory L Brower; Jason D Gardner; Amanda L Chancey; James A Stewart
Journal:  Heart Fail Rev       Date:  2004-01       Impact factor: 4.214

Review 3.  Myocardial neovascularization by adult bone marrow-derived angioblasts: strategies for improvement of cardiomyocyte function.

Authors:  Silviu Itescu; Alfred A Kocher; Michael D Schuster
Journal:  Heart Fail Rev       Date:  2003-07       Impact factor: 4.214

Review 4.  Single photon emission computed tomography perfusion imaging for assessment of myocardial viability and management of heart failure.

Authors:  Steven Burrell; Sharmila Dorbala; Marcelo F Di Carli
Journal:  Curr Cardiol Rep       Date:  2003-01       Impact factor: 2.931

5.  On the fate of skeletal myoblasts in a cardiac environment: down-regulation of voltage-gated ion channels.

Authors:  H C Ott; S Berjukow; R Marksteiner; E Margreiter; G Böck; G Laufer; S Hering
Journal:  J Physiol       Date:  2004-06-11       Impact factor: 5.182

6.  Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy.

Authors:  Q Li; B Li; X Wang; A Leri; K P Jana; Y Liu; J Kajstura; R Baserga; P Anversa
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

7.  Tl-201 washout rate in remote normal regions in patients with prior myocardial infarction and left ventricular remodeling.

Authors:  Toshihiko Goto; Nobuyuki Ohte; Hiromichi Miyabe; Seiji Mukai; Seiichiro Sakata; Junichiro Hayano; Genjiro Kimura
Journal:  J Nucl Cardiol       Date:  2005 Mar-Apr       Impact factor: 5.952

8.  Unraveling the mechanistic basis of mesenchymal stem cell activity in the heart.

Authors:  Loren J Field
Journal:  Mol Ther       Date:  2006-10-27       Impact factor: 11.454

9.  Protective effects of Jiashen Prescription () on myocardial infarction in rats.

Authors:  Ming-Jun Zhu; You-Ping Wang; Shi-Yang Xie; Wei-Hong Liu; Bin Li; Yong-Xia Wang; He Wang; Bo-Li Zhang
Journal:  Chin J Integr Med       Date:  2014-05-10       Impact factor: 1.978

10.  Reduced expression of Cx43 attenuates ventricular remodeling after myocardial infarction via impaired TGF-beta signaling.

Authors:  Yan Zhang; Hongtao Wang; Attila Kovacs; Evelyn M Kanter; Kathryn A Yamada
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-12-04       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.